News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard May 22, 2023 Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference May 8, 2023 Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More" May 5, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 4, 2023 Insmed Reports First Quarter 2023 Financial Results and Provides Business Update Apr 24, 2023 Insmed to Host Investor and Analyst Event on May 8, 2023 Apr 20, 2023 Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023 Apr 6, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Mar 31, 2023 Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Mar 24, 2023 Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference Mar 3, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Show 5102550100 per page«123456789…66» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download